scholarly journals Improvement of Bone-Sparing Effect of Soy Isoflavones by Pre- and Probiotics in Postmenopausal women

2008 ◽  
Vol 1 ◽  
pp. CMWH.S1034
Author(s):  
J. Mathey ◽  
V. Lamothe ◽  
C. Bennetau-Pelissero ◽  
M.J. Davicco ◽  
F. Tondu ◽  
...  
Nutrients ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 1407
Author(s):  
Jihyun Im ◽  
Kyong Park

The association between soy food and soy isoflavone intake and cardiovascular disease (CVD) risk is uncertain, especially in women. We aimed to investigate this association in Korean women. We analyzed data from the Korean Genome and Epidemiology Study, including 4713 Korean women aged 40–69 years with no CVD or cancer at baseline. Dietary information was obtained using a validated semi-quantitative food frequency questionnaire, and the incidence of CVD was assessed using biennial self-reported questionnaires on medical history. The mean follow-up time was 7.4 years, during which 82 premenopausal and 200 postmenopausal women reported CVD incidence. The highest tofu, total soy foods, and dietary soy isoflavone intake groups were significantly associated with a decreased CVD risk in premenopausal women (tofu: hazard ratio (HR) 0.39; 95% confidence interval (CI), 0.19–0.80; total soy food: HR 0.36; 95% CI, 0.18–0.70; dietary soy isoflavones: HR 0.44; 95% CI, 0.22–0.89), whereas no association was observed in postmenopausal women. Other soy foods showed no association with CVD incidence. Dietary soy isoflavones and total soy foods are associated with a decreased CVD risk in premenopausal women. Among soy foods, only tofu showed significant health benefits.


Phytomedicine ◽  
2011 ◽  
Vol 18 (4) ◽  
pp. 245-250 ◽  
Author(s):  
Placido Llaneza ◽  
Celestino González ◽  
José Fernandez-Iñarrea ◽  
Ana Alonso ◽  
Fernando Diaz ◽  
...  

2008 ◽  
Vol 138 (7) ◽  
pp. 1288-1292 ◽  
Author(s):  
Wendy L. Hall ◽  
Nichola L. Formanuik ◽  
Duangporn Harnpanich ◽  
Monique Cheung ◽  
Duncan Talbot ◽  
...  

2011 ◽  
Vol 14 (1) ◽  
pp. 47-57 ◽  
Author(s):  
Kristine M. Shedd-Wise ◽  
D. Lee Alekel ◽  
Heike Hofmann ◽  
Kathy B. Hanson ◽  
Dan J. Schiferl ◽  
...  

2009 ◽  
Vol 91 (1) ◽  
pp. 218-230 ◽  
Author(s):  
D Lee Alekel ◽  
Marta D Van Loan ◽  
Kenneth J Koehler ◽  
Laura N Hanson ◽  
Jeanne W Stewart ◽  
...  

2021 ◽  
Vol 11 ◽  
pp. 184-195
Author(s):  
Sara Tutunchi ◽  
Mehdi Koushki ◽  
Nasrin Amiri-Dashatan ◽  
Hadi Khodabandehloo ◽  
Hossein Hosseini ◽  
...  

Decreased adiponectin levels has been demonstrated in postmenopausal (PMP) women. Soy isoflavones, as an herbal product have been shown to increase adiponectin level but the results are inconclusive and inconsistent. The present study reassessed the data on the impact of soy isoflavones supplementation on adiponectin levels in PMP women through a meta-analysis. A systematic search was performed in the databases of PubMed, Web of science, Scopus and the Cochrane library. The literature search identified 830 studies with duplicates. Out of those, 80 were screened for title and abstract and 12 articles were ultimately selected for the analysis. Meta-regression and subgroup analyses, based on the moderator variables such as treatment duration, dose of soy isoflavones and BMI were performed. The quality of the studies was evaluated using the Grading of Recommendation Assessment, Development and Evaluation (GRADE) approach. The results revealed that soy isoflavones supplementation significantly increased the circulating level of adiponectin in PMP women (SMD: 0.36 µg/mL; 95% CI (0.05 to 0.66); P= 0.02). No publication bias was observed using Begg's (P = 0.38) and Egger's (P = 0.07) tests. Sensitivity analysis indicated the results were completely powerful and stable. Moreover, Meta-regression and subgroup analyses indicated a significant increase of adiponectin levels in subgroups of dose > 50 mg and treatment duration less or equal 3 months. Our findings showed significantly increase in adiponectin levels after isoflavones-supplemented soy consumption in postmenopausal women, who received dose > 50 mg of soy isoflavones in treatment duration ≤ 3 months.


Sign in / Sign up

Export Citation Format

Share Document